Hypoxia may be a promising therapy path to address Parkinson's neurodegeneration caused by excessive oxygen levels in the brain.

Agg-CLNP synergized with abatacept to delay RA-related inflammation and with dexamethasone to prevent flare-ups following ...

A bacteria-based cancer therapy has been engineered that eradicates tumors in immunocompromised mice—no immune cells required.

Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...

In addition to cell line development, CHO Plus partnered to scale up Avid Bioservices' mAb production to meet industrial scale requirements.

In this GEN webinar, eight experts discuss collaborative strategies and technological innovations that are shaping the future of malaria drug development.

A comprehensive genetic analysis of nearly one million people has identified 53 lead variants associated with aging-related frailty.

PacBio develops the Platinum Pedigree benchmark, a new standard for accurate characterization of variation in the human genome.

The fusion of intelligent modeling workflows, PAT, and smart devices will allow biomanufacturers to drastically reduce development costs.

Researchers have elucidated structure-activity relationships underlying a key serotonin receptor shown to regulate mood and cognition.

The new facility will be Asahi Kasei Life Science's fourth spinning plant for hollow-fiber cellulose membrane filters.

Murine study finds eIF2A dependence emerges only after malignant transformation, suggesting a therapeutic window that may spare healthy tissues.